COVID-19

COVID-19 In Vitro Diagnostic Tests Development & Consulting
 

Image
The global SARS-CoV-2 coronavirus (COVID-19) pandemic has laboratory diagnostic researchers and developers racing to meet the demand for assays.  In vitro diagnostic tests are the bedrock and main COVID-19 intervention. Diagnostic tests are used not only to detect the virus, but also used to assess immune response, predict disease severity through prognostics, monitor treatment and disease progression and to also conduct surveillance. Test, Treat, Trace.

There is not a one size fits all diagnostic for all the scenarios that a SARS-coV-2 infection may or may not cause.  Some individuals may be pre-symptomatic when tested, some may be asymptomatic, some may be in the acute phase and some may be in the recovery phase or well beyond.

- Partner with POCA International LLC -
 

Poca logo
POCA International is at the center of this fight, assisting SARS-CoV-2 and infectious disease researchers and diagnostic test developers with its diverse expert capacities.  Whether you are looking for help with product development strategy, manufacturing partner (reagent lyophilized beads, software, analyzer, plastics), regulatory assistance or market research, commercialization strategy, we are here to partner with you toward success.

Whether your Dx assay is Molecular qPCR, Isothermal, Antibody (binding or neutralizing), or Antigen based, via numerous platforms, traditional or POC, diagnostic assays continue to be vital in combating the COVID-19 pandemic.

Please contact us to assist your team in the endeavor of providing high quality, ease of use, scalable yet affordable products to fight this pandemic. If you have other exciting disruptive ideas or initiatives in vitro diagnostics, medical device and technologies to improve global health, we look forward to hearing from you.

 

- Get in Touch -

Thank you for your interest. Use the form below to request a consultation or to ask a question.  Give us a call: 883-762-2483